Related Experiment Video

Updated: Aug 19, 2026

Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
07:25

Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology

Published on: March 27, 2018

Evidence that lack of brain dopamine during development can increase the susceptibility for aggression and

G R Breese1, H E Criswell, R A Mueller

  • 1Brain and Development Research Center, University of North Carolina, School of Medicine, Chapel Hill.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|January 1, 1990
PubMed

Insights

Lesch-Nyhan disease involves neurological issues, aggression, and self-harm. D1-dopamine antagonists show promise in treating these symptoms by targeting dopamine pathways, potentially helping patients with aberrant behaviors.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Genetics

Background:

  • Lesch-Nyhan disease presents with distinct neurological deficits, including abnormal motor function, aggression, and self-injurious behaviors.
  • A dopamine deficiency is a key feature of Lesch-Nyhan disease, which can be experimentally modeled.

Purpose of the Study:

  • To investigate the potential therapeutic role of D1-dopamine antagonists in managing aggression and self-injurious behavior associated with Lesch-Nyhan disease.
  • To evaluate the efficacy of D1-dopamine antagonists in a preclinical model of Lesch-Nyhan disease.

Main Methods:

  • Neonatal rats were treated with 6-hydroxydopamine (6-OHDA) to create a model of dopamine deficiency, mimicking Lesch-Nyhan disease.
  • The effects of D1-dopamine antagonists on L-DOPA-induced self-injurious behavior were assessed in the 6-OHDA-lesioned rat model.

Main Results:

  • D1-dopamine antagonists effectively blocked L-DOPA-induced self-injurious behavior in neonatal 6-OHDA-lesioned rats.
  • The drug SCH-12679, a known D1-dopamine antagonist, demonstrated effectiveness against aggressiveness in patients with intellectual disabilities.

Conclusions:

  • D1-dopamine antagonists represent a promising therapeutic strategy for addressing aggression and self-injurious behaviors in Lesch-Nyhan disease.
  • Further development of D1-dopamine antagonists may offer effective treatments for specific aberrant behaviors in patient populations with neurological conditions.

More Related Videos

Social Defeat Stress Model for Adolescent C57BL/6 Male and Female Mice07:15

Social Defeat Stress Model for Adolescent C57BL/6 Male and Female Mice

Published on: March 15, 2024

Developing a Rat Model for Bipolar Disorder04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...